Skip to content
Latest
STOX.NEWS
In focus

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

Advertisement
Demo creative for ADG8 Article body (336x280)

Companies named

More on this